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Abstract
Myeloid-derived suppressor cells (MDSCs) in mouse are inflammatory cells that play critical
roles in promoting cancer growth and metastasis by directly stimulating cancer cell prolifera-
tion and suppressing immune surveillance. In order to facilitate characterization of biochem-
ical and cellular mechanisms of MDSCs, it is urgent to establish an “MDSC-like” cell line. By
cross breeding of immortomouse (simian virus 40 large T antigen transgenic mice) with wild
type and lysosomal acid lipase (LAL) knock-out (lal-/-) mice, we have established a wild
type (HD1A) and a lal-/- (HD1B) myeloid cell lines. Compared with HD1A cells, HD1B cells
demonstrated many characteristics similar to lal-/-MDSCs. HD1B cells exhibited increased
lysosomes around perinuclear areas, dysfunction of mitochondria skewing toward fission
structure, damaged membrane potential, and increased ROS production. HD1B cells
showed increased glycolytic metabolism during blockage of fatty acid metabolism to fuel
the energy need. Similar to lal-/-MDSCs, the mTOR signal pathway in HD1B cells is overly
activated. Rapamycin treatment of HD1B cells reduced ROS production and restored the
mitochondrial membrane potential. HD1B cells showed much stronger immunosuppression
on CD4+ T cell proliferation and function in vitro, and enhanced cancer cells proliferation.
Knockdown of mTOR with siRNA reduced the HD1B cell ability to immunosuppress T cells
and stimulate cancer cell proliferation. Therefore, the HD1B myeloid cell line is an “MDSC-
like” cell line that can be used as an alternative in vitro system to study how LAL controls
various myeloid cell functions.
Introduction
Myeloid-derived suppressor cells (MDSCs) are myeloid progenitors that are blocked to further
differentiate into granulocytes, macrophages, and dendritic cells at various pathogenic condi-
tions [1,2]. In mice, MDSCs are broadly defined as CD11b+Gr-1+ cells. MDSCs in the tumor
microenvironment have been suggested to have a causative role in directly stimulating cancer
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cell proliferation and promoting tumor-associated immune suppression. Since MDSCs may
serve as a target for preventing tumor growth and metastasis, there is a need to establish in
vitro “MDSCs-like” cell lines to facilitate MDSCs studies at the cellular and molecular levels.
Fatty acid metabolism supports both the biosynthetic and bioenergetic requirements of cell
proliferation and survival. Lipids are essential components of plasma and organelle mem-
branes, and can function as secondary messengers for signal pathways. In addition to glycolytic
metabolic pathway, free fatty acids oxidation (FAO) also serves as an important metabolic fuel
for energy production (e.g., ATP) on the mitochondrial electron transportation chain. Lyso-
somal acid lipase (LAL) is an essential enzyme that hydrolyzes cholesteryl esters (CE) and tri-
glycerides (TG) to generate free fatty acid (FA) and cholesterol in lysosomes. Lack of LAL in
humans leads to two human lipid storage diseases, Wolman disease (WD) and CE storage dis-
ease (CESD). Increased CD14+CD16+ and CD14+CD33+ cells have been linked to heterozygote
carriers of LAL mutations in humans [3]. CD14+ CD16+ and CD33+ are the markers used for
human subset of MDSCs identification [4]. In mice, lack of LAL in genetically ablated knock-
out mice (lal-/-) shows systemic expansion of MDSCs, which influences the tissue microenvi-
ronment and contributes to local pathogenesis [5–7] [8,9] [10]. Lal-/-MDSCs directly
stimulate cancer cell proliferation [11], and suppress T cell proliferation and impair T cell func-
tion [12]. Myeloid-specific expression of human LAL in lal-/-mice reverses tissue inflamma-
tion, MDSCs infiltration, and corrects malformation and dysfunction of MDSCs [13,14].
In order to fully understand the functional role of LAL in MDSCs development, the Affyme-
trix Genechip microarray assay was performed. The gene profile showed upregulation of meta-
bolic enzyme genes in glycolysis and citric acid cycle in association with over-activation of the
mTOR signaling pathway in lal-/-MDSCs in which their fatty acid generation is blocked [15].
The mTOR signaling regulates nutrient energy and metabolism, controls cell growth and divi-
sion [16]. The mTOR signaling pathway plays a critical role in modulating immune functions
[17]. Inhibition of mTOR pharmacologically or by siRNA knockdown reduces lal-/-MDSCs
abilities to stimulate cancer cell proliferation and to suppresses T cell proliferation and function
[11,18].
Mitochondria fission (fragment or dot shape) and fusion (filamentous) play critical roles in
maintaining functional mitochondria when cells are under metabolic or environmental stress
[19]. Studies have reported that mitochondria fission and fusion respond to cellular triglyceride
accumulation [20]. Since the mTOR pathway is highly activated, mitochondria membrane po-
tential is damaged, and the ROS level is elevated in lal-/-MDSCs [18], it is essential to examine
the mitochondria fission and fusion in these MDSCs like cells.
In this report, immortalized wild type lal+/+ HD1A and lal-/- HD1B myeloid lineage cell
lines were established from wild type and lal-/-mice that were crossbred with Immortomouse
expressing a temperature-sensitive version of simian virus 40 large T antigen. The key charac-
ters of MDSCs were analyzed in HD1A and HD1B cell lines. HD1B cells showed higher prolif-
eration than that of HD1A cells. This is accomplished by high consumption of glucose
oxidation in the mitochondria to compensate the deficiency of FAO. Similar to its primary pre-
cursor lal-/- MDSCs, lal-/- HD1B myeloid cells in vitro showed stronger immunosuppression
on T cells, and stronger stimulation on cancer cell proliferation compared with its wild type
counterpart HD1A cells. At the cellular level, HD1B cells showed characteristics of lal-/-
MDSCs, including over-activation of the mTOR signaling pathway, increased production of re-
active oxygen species (ROS), arginase activity, and damaged membrane potential. At the sub-
cellular level, the mitochondrial organization of HD1B cells morphologically showed more
fission structure in association with down-regulation of pro-fusion protein Opa1 and phos-
phorylated activation of pro-fission protein Drp1, while the mitochondrial organization of
wild type HD1A cells showed more fusion structure. Establishment of these cell lines will not
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only facilitate elucidation of cellular and molecular mechanisms that are involved in MDSCs
malformation and malfunction, but also provide an in vitro system to screen drugs for pharma-
cological and immune therapy purposes.
Materials and Methods
Ethics Statement
All scientific protocols involving the use of animals have been approved by the Institutional
Animal Care and Use Committee of Indiana University School of Medicine and followed
guidelines established by the Panel on Euthanasia of the American Veterinary Medical Associa-
tion. Animals were housed under Institutional Animal Care and Use Committee-approved
conditions in a secured animal facility at Indiana University School of Medicine.
HD1A and HD1Bmyeloid cell line establishment from isolation of
immortalized mouse myeloid lineage cells
Peritoneal macrophages were collected from wild type and lal-/-male mice that had been cross-
bred with Immortomouse (Charles River Laboratories) expressing a temperature-sensitive ver-
sion of simian virus 40 large T antigen from an IFN-γ inducible promoter [21]. Cell
suspensions were obtained by peritoneal lavage with 8 ml of PBS, washed, and cells were cul-
tured at 33°C in RPMI medium 1640 supplemented with 10% FBS, antibiotics, and 5 units/ml
IFN-γ. After 10 passages, IFN-γ was omitted from the medium.
Living cell lysosome staining
HD1A and HD1B cells were grown in 24-well plates to the desired confluence. The medium
were replaced with pre-warmed (37°C) LysoTracker Red DND-99 probe (50nM, Molecular
Probes)-containing medium for 1 hour. Cells were replaced with fresh medium, and fluores-
cent signals were examined under the Nikon ECLIPSE Ti inverted fluorescence microscope.
Glucose and pyruvate measurement
The concentration of glucose and pyruvate was measured by the glucose assay kit and pyruvate
assay kit (Sigma) respectively according the manufacturer’s instruction. Briefly, HD1A or
HD1B cells were washed with PBS before being harvested. The cell pellets were added with
pre-warmed water and headed in the 70°C water bath for 10 minutes. After spinning down the
cell lysates, for glucose measurement the supernatants were incubated with glucose assay re-
agent for 15 minutes at room temperature and measured absorbance at the 340 nm. For pyru-
vate measurement, the supernatants were incubated with pyruvate assay buffer, pyruvate probe
solution and pyruvate enzyme mixture for 30 minutes at room temperature and measured ab-
sorbance at the 570 nm.
Aconitase activity assay
The aconitase activity was measured by the aconitase activity assay kit (Sigma) according the
manufacturer’s instruction. Briefly, HD1A or HD1B cells were washed with PBS before being
harvested. Cells were lysed in the ice-cold assay buffer. After centrifugation, the aconitase acti-
vation buffer was added into supernatant and incubated on ice for 1 hour, followed by adding
Enzyme Mix, assay buffer and the substrate at 25°C for 30 minute. After addition of developer
to the incubation mixture at 25°C for 10 minute, the reactions were measured at the 450 nm
absorbance. One unit of the aconitase activity is the amount of enzyme that isomerize
1.0 μmole of citrate to isocitrate per minute at pH 7.4 at 25°C.
MDSC-Like Cells
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Living cell mitochondrial staining
HD1A and HD1B cells were grown in 24-well plates to the desired confluence. The medium
were replaced with pre-warmed (37°C) MitoTracker Green FM (100 nM, Molecular Probes)-
containing medium for 1 hour. Cells were replaced with fresh medium, and fluorescent signals
were examined under the Nikon ECLIPSE Ti inverted fluorescence microscope.
Immunofluorescence
HD1A and HD1B cells were fixed for 15 min in 4% paraformaldehyde, and permeabilized for
10 min in 0.02% Triton X 100. After washing, cells were blocked with 5% normal goat serum in
1 x PBS for 1 hour followed by incubation of primary goat anti-LAMP1 antibody (1:200, Santa
Cruz) overnight. Cells were then incubated with secondary donkey anti-goat antibody conju-
gated with Cy3 (1:1000, Jackson ImmunoResearch) for 1 hour, and co-stained with DAPI.
Fluorescent signals were examined under the Nikon fluorescence microscope.
Western blot
HD1A and HD1B cells were lysed in the Cell Lytic M mammalian cell lysis/extraction buffer
(Sigma-Aldrich) according to the manufacturer’s instruction. Protein samples were fractionat-
ed on a Novex 4–20% Tris-Glycine Mini Gel (Invitrogen). After transferring to the polyvinyli-
dene difluoride membrane (Bio-Rad), the membrane was blotted with 5% nonfat dry milk in
1x PBS, and incubated with rabbit anti-p-S6 (Ser235/236), anti-S6, anti-p-Drp1 (Ser616), anti-
Drp1, and anti-actin primary antibodies (from Cell Signaling), or rat anti-LAMP1, rabbit anti-
Opa1 antibodies (from Santa Cruz). Following incubation with the secondary antibody that
conjugated with horse radish peroxidase, proteins were visualized with chemiluminescent sub-
strate (Thermo Scientific) under ChemiDox MP Image System.
ROSmeasurement
HD1A and HD1B cells were treated with solvent, rapamycin (40 nM), or PP242 (40 nM) for
60 minutes. Cells were washed and stained with 2 μM of 2',7'-dichlorodihydrofluorescein dia-
cetate stained (DCFDA, Invitrogen) which is nonfluorescent until the acetate group is removed
by intracellular esterases and oxidation occurs within the cell (Invitrogen). The incubation was
at 37°C for 20 minutes, followed by washing with cold PBS. The ROS level was measured by
flow cytometry.
Arginase activity measurement
HD 1A or HD1B cells were lysed for 30 min at room temperature with 50 μl 0.1% Triton
X-100 PBS containing 5 μg pepstatin, 5 μg aprotinin, and 5 μg antipain protease inhibitors per
ml. Subsequently, 50 μl 10 mMMnCl2 and 50 μl 50 mM Tris-HCl (pH 7.5) were added, and
the enzyme was activated by heating at 56°C for 10 min. Arginine hydrolysis was conducted by
incubating the lysate (100 μl) with 100 μl 0.5 M L-arginine (pH 9.7) at 37°C for 60–120 min.
The reaction was stopped with 400 μl H2SO4 (96%)/H3PO4 (85%)/H2O (1:3:7, v/v/v). The urea
concentration was measured at 540 nm after addition of 25 ml 9% α-isonitrosopropiophenone
(dissolved in 100% ethanol), followed by heating at 95°C for 45 min and 10 min at room tem-
perature in the dark. One unit of enzyme activity is defined as the amount of enzyme that cata-
lyzes the formation of 1 μmol urea per minute.
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T cell proliferation and lymphokine release assays in vitro
Freshly isolated wild type CD4+ T cells from the spleen were labeled with carboxyfluorescein
diacetate succinimidyl diester (CFSE, Molecular Probes) (1 μM in PBS) at room temperature
for 5 min, and resuspended in complete medium for 20 min. CD4+ T cells were spun down
and cultured in 96-well flat-bottom plates coated with anti-CD3 mAb (2 μg/ml) and anti-
CD28 mAb (5 μg/ml) for 4 days in the presence or absence of HD1A or HD1B cells at 37°C.
The ratio between HD1A or HD1B cells and CD4+ T cells was 1:30. Cells were harvested and
stained with APC-labeled anti-CD4 mAb (eBiosciences). Proliferation of CD4+ T cells was
evaluated as CFSE dilution by FACS. To measure T cell secreting lymphokines, OptEIA ELISA
kits for IL-2, IL-4 and IFNγ were used according to the manufacturer’s instruction (BD
BioScience).
HD1A and HD1B cell surface marker staining
HD1A and HD1B cells were harvested and stained with anti-CD11b-PEcy7 and anti-
Ly6G-Apccy7 for flow cytometry analysis.
mTOR knockdown by siRNAs
HD1A and HD1B cells were transfected with mTOR—specific or scrambled control siRNAs
(final concentration 25 nM) according to the manufacturer’s protocol (Dharmacon, Lafayette,
CO). After 48 hours incubation, cells were washed and co-cultured in wells with CFSE-labeled
wild type CD4+ T cells (1:30) for T cell proliferation (96 hours) and lymphokine release study
(48 hours), or lysed to test mTOR signaling pathway protein expression, or co-cultured with
B16 or LLC cancer cells, or labeled for BrdU incorporation study.
Mitochondrial membrane potential assay
HD1A and HD1B cells were grown in 24-well plates to the desired confluence. Cells were treat-
ed with solvent (DMSO, 0.1%), rapamycin (40 nM), or PP242 (40 nM) for 1 hour, or NAC
(100 μM, Sigma-Aldrich), or Tempol (10 μM, Sigma-Aldrich) overnight. Treated cells were re-
placed with the pre-warmed (37°C) medium containing JC1 (5 μM, Molecular Probes) for
1 hour. Labeled cells were replaced with fresh medium and examined under the Nikon inverted
fluorescence microscope.
BrdU incorporation
For cell proliferation analysis, HD1A and HD1B cells were grown in 24-well plate to the de-
sired confluence. BrdU (BD Biosciences) was added at a final concentration of 10 μM in cell
culture medium for 1 hour. Cells were harvested and washed twice with PBS. Cells were fixed
and permeabilized with BD Cytofix/Cytoperm buffer, then incubated with DNase I and washed
again followed by staining with fluorescent anti-BrdU antibody before analysis by
flow cytometry.
Cancer cell proliferation in vitro
B16 melanoma or LLC cancer cells were harvested and labeled with CFSE (1 μM in PBS) at
room temperature for 5 min. Labeled cancer cells were resuspended in complete medium for
20 min, spun down, and co-cultured with HD1A or HD1B cells (1:5, 3 x104 cells per well of
24-well plate). After culture for 3 days, the cells were harvested and analyzed on the LSR II to
determine cancer cell proliferation by gating CFSE labeled cells.
MDSC-Like Cells
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Cancer cell growth in vivo
B16 melanoma cells (2 X 105) were mixed with HD1A or HD1B cells (2 X 105) and injected
subcutaneously at left or right flank sites of C57BL/6 or FVB/N mice. The tumor sizes were
measured 14 days post-injection with calipers. The tumor volumes were determined using the
formula: (length X width2) /2 [11]. At the end of the experiment, the animals were euthanized.
Real-Time PCR
Total RNAs from HD1A or HD1B cells were purified using the Qiagen total RNA purification
kit (Qiagen). cDNAs were generated by SuperScript III (Invitrogen). Real-Time PCR for CD36,
CPT1a, CPT1b, CPT1c, Foxo3, Glut1-13, IDO1, IDO2, SIRT1 and the housekeeping gene
β-Actin was performed on a StepOnePlusReal-Time PCR System (Applied Biosystems) using
Power SYBR Green PCR Master Mix (Applied Biosystems) according to the manufacturer’s
protocol. The (2-̇ΔΔCt) algorithm was used to determine the relative gene expression.
Results
Lysosome accumulation in lal-/-macrophage cell lines
To generate HD1A and HD1B cells, wild type and lal-/- mice were crossbred with Immorto-
mouse (Charles River laboratory), which express a temperature-sensitive simian virus 40 T an-
tigen under an INF-γ inducible promoter. HD1A and HD1B cell lines were established and
passaged as described in Materials and Methods. As LAL is a lysosome localized enzyme, the
lysosome numbers and localization were examined in HD1A and HD1B cells. Western blot
analysis showed an increased LAMP1 (a marker for lysosome) expression level in HD1B cells
compared with that of HD1A (Fig. 1A). Immunofluorescent staining of LAMP1 showed in-
creased lysosomal numbers in HD1B cells around the perinuclear area (Fig. 1B). This was con-
firmed by another lysosome specific dye LysoTracker Red DND-99 staining (Fig. 1C). The
malfunction of HD1B was assessed by several molecules that are involved in fatty acid uptake
and function, including CD36, forkhead box O (FoxO3), and SIRT1. CD36 or FOXO3 expres-
sion was increased in HD1B cells compared with HD1A cells, while SIRT1 remained no change
(Fig. 1D). We also investigated another important group of FA transporters, carnitine palmi-
toyl transferase (CPT1a, CPT1b and CPT1c) that transports long-chain FA into the mitochon-
dria and are a rate limiting step of mitochondrial fatty-acid oxidation (FAO). None of these
transporters showed expression changes in HD1B cells compared with those in HD1A cells
(Fig. 1D), suggesting no increased activity of this pathway for FA transportation into the mito-
chondria during LAL dysfunction. Taken together, these results indicate that LAL deficiency
increases lysosome genesis and the abnormal activities of fatty acid metabolism in HD1B
myeloid cells.
Glucose level, pyruvate level, aconitase activity, and GLUT expression
in HD1A and HD1B cells
Compared with HD1A cells, HD1B cells showed increased glucose concentration (Fig. 2A),
suggesting the enhanced glycolysis metabolic pathway, in which glucose converts into pyru-
vate. Indeed, the pyruvate concentration was increased in HD1B cells compared with that in
HD1A cells (Fig. 2A). Glycolysis occurs in the cytosol of the cell. Pyruvic acid supplies energy
to living cells through the citric acid cycle (TCA) in the mitochondria, which generates NADH
for the oxidative phosphorylation (OXPHOS, electron transport pathway) to produce ATP.
Aconitase is the rate-limiting enzyme in the TCA cycle. Its activity was doubled in HD1B cells
compared with HD1A cells (Fig. 2A). The high glycolysis metabolic rate and TCA turnover
MDSC-Like Cells
PLOS ONE | DOI:10.1371/journal.pone.0121001 March 25, 2015 6 / 20
promoted us to investigate GLUT (SLC2) family members [22]. These are the major membrane
transporters. Among them, GLUT 1–5 have been well characterized as glucose and/or fructose
transporters in various tissues and cell types. Thirteen GLUT proteins have been reported to be
expressed in mice (14 in humans). Using the Real-time PCR method, expression of all GLUT
members was assessed in HD1A and HD1B cells, in which GLUT3, GLUT6, GLUT8, GLUT12,
Fig 1. Increase of lysosome genesis andmetabolic disorder in HD1B cells. (A) Western blot analysis of
lysosomemarker LAMP1 expression in wild type (HD1A) and lal-/- (HD1B) cells; (B) Immunofluorescence
staining of LAMP1 in wild type (HD1A) and lal-/- (HD1B) cells. Bars = 20 μm; (C) LysoTracker Red DND-99
staining of live wild type (HD1A) and lal-/- (HD1B) cells. Bar = 25 μm. (D) Expression of CD36, Foxo3, Sirt1,
CPT1, CPT2, CPT3 with the housekeeping gene β-Actin as internal control by Real-time PCR. The results
are means ± SD from three independent experiments (n = 3), *, p< 0.05, **, p< 0.001.
doi:10.1371/journal.pone.0121001.g001
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and CLUT13 were upregulated, while GLUT 5 and GLUT 9 were downregulated in HD1B cells
(Fig. 2B). This supports a concept that the neutral lipid metabolic pathway controls the balance
of glucose transportation to fuel the energy need in myeloid cells.
Mitochondrial morphology change in HD1B cells
As demonstrated above, compared to HD1A cells the glycolytic pathway in HD1B cells are en-
hanced and utilized to fuel the energy need for this transition. Mitochondria are central
Fig 2. Glucose transportation, glycolysis and TCA in HD1A and HD1B cells. (A) The glucose and
pyruvate concentrations, and aconitase activity in wild type (HD1A) and lal-/- (HD1B) cells. The results are
means ± SD from three independent experiments (n = 3), *, p< 0.05, **, p< 0.001. (B) Expression ofGlut1
to Glut13 with the housekeeping gene β-Actin as internal control by Real-time PCR. The results are
means ± SD from three independent experiments (n = 3), *, p< 0.05, **, p< 0.001.
doi:10.1371/journal.pone.0121001.g002
MDSC-Like Cells
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organelles in carbohydrate, lipid and amino acid metabolisms in cells. Glycolytic metabolic in-
flux into mitochondria and enter the TCA cycle to enhance mitochondrial respiration on the
mitochondrial electron transport chain (ETC). Mitochondria are double-membrane—bound
subcellular organelles of eukaryotic cells with various functions, including oxidative-phosphor-
ylation, apoptosis, and ROS production. In order to fully understand pathogenic malformation
and malfunction in HD1B cells, it is necessary to characterize and compare mitochondrial
structures in HD1A and HD1B cells for comparison. It has been well documented that the mi-
tochondrial fission and fusion processes play critical roles in governing these mitochondrial
functions [19,23]. Using mitochondria-specific labeling dye Mit G, mitochondria in HD1B
cells showed more fission shaped structure (dots) when compared with more fusion shaped
structure in HD1A cells (Fig. 3A). The fission process of mitochondria is engaged in a more
Fig 3. Themorphological change of mitochondria in wild type (HD1A) and lal-/- (HD1B) cells. (A)
MitoTracker Green FM staining of live wild type (HD1A) and lal-/- (HD1B) cells. Bar = 25 μm. (B) Cell
proliferation of wild type (HD1A) and lal-/- (HD1B) cells in vitro; (C) Western blot analyses of protein
expression of Opa1 and phosphorylation at Ser616 of DRP1 in wild type (HD1A) and lal-/- (HD1B) cells. (D)
Concentrations of glucose, pyruvate and the aconitase activity in HD1A and HD1B cells were measured.
Results are means ± SD from three independent experiments (n = 3), *, p< 0.05.
doi:10.1371/journal.pone.0121001.g003
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proliferative state [19,23]. Indeed, HD1B cells are more proliferative than HD1A cells (Fig. 3B).
This observation is also in consistence with higher transportation and consumption of glucose
as outlined in Fig. 1. Opa1 is a key mediator controlling mitochondrial fusion. Western blot
analysis showed a decreased level of Opa1 expression in HD1B cells compared with that of
HD1A cells (Fig. 3C, left panel). On the other hand, Drp1 is a key mediator controlling mito-
chondrial fission. Phosphorylation on Ser616 activates Drp1 to stimulate mitochondrial fission.
In HD1B cells, phosphorylation on Ser616 of Drip1 was increased significantly (Fig. 3C, right
panel). Therefore, LAL deficiency in HD1B cells leads to mitochondrial fusion to fission con-
version, a more proliferative state.
Mitochondrial dysfunction in HD1B cells
To see if the structural change leads to functional changes, the mitochondrial membrane po-
tential and ROS production, which are coupled with OXPHOS, were measured in HD1A and
HD1B cells. The mitochondrial membrane potential was analyzed by JC1 staining. While most
HD1A cells were stained with red fluorescence staining (representing healthy mitochondria),
HD1B cells were stained with less red fluorescence and more green fluorescence (representing
damaged mitochondria) (Fig. 4A). A damaged mitochondrial membrane potential restricts
electron flow and increases the leakage of electrons to form ROS through the electron transport
chain. Indeed, increased ROS production in HD1B cells was observed (Fig. 4B). Compared
with that in HD1A cells, HD1B cells also increased the arginase activity, which is another im-
portant characteristic parameter of MDSCs (Fig. 4C). These phenotypes resemble to what were
observed in lal-/- MDSCs [15]. Because tryptophan (Trp) metabolizing enzyme indoleamine
2,3-dioxygenase (IDO) plays a pivotal role in MDSCs via suppressing T cell function [24], ex-
pression of both IDO1 and IDO2 were measured in HD1A and HD1B cells. Interestingly, only
IDO2 was highly overexpressed in HD1B cells (Fig. 4D). Therefore, there are profound differ-
ences between the mitochondrial structures and functions in HD1A and HD1B cells.
mTOR inhibition or antioxidant treatment rescued abnormal HD1B
phenotypes
Previously, Affymetrix GeneChip microarray showed over-activation of the mTOR signaling
pathway in association with mitochondrial membrane potential damage and ROS over-pro-
duction in lal-/- MDSCs [15]. To see if mTOR is overly activated in HD1B cells, rapamycin or
PP242 were used to suppress the mTOR signaling pathway. As demonstrated by the Western
blot result, both inhibitors blocked mTOR downstream effector S6 phosphorylation in HD1A
and HD1B cells (Fig. 5A). The treatment also decreased ROS production (Fig. 5B) and reversed
the damaged mitochondrial membrane potential in HD1B cells (Fig. 5C). To confirm that ROS
over-production is responsible for the damage of the mitochondrial membrane potential in
HD1B cells, antioxidant NAC or TEMPOL was used to diminish ROS. This treatment
partially improved the condition of the mitochondrial membrane potential as shown with
more red JC-1 fluorescence staining in HD1B cells (Fig. 5D).
Immunosuppressive function of HD1B cells
Immunosuppression is the hallmark of MDSCs. To see if HD1B cells possess immunosuppres-
sive function, HD1B cells (or HD1A cells as control) were co-cultured with CFSE-labeled sple-
nocyte CD4+ T cells in the anti-CD3 and anti-CD28 antibody coated plate. After 4 days, CD4+
T cell proliferation was analyzed by flow cytometry. Compared with HD1A cells, HD1B cells
showed a stronger suppressive function on CD4+ T cell proliferation (Fig. 6A). Lymphokine re-
lease of INFγ (TH1) and IL-4 (TH2) by CD4+ T cells was also decreased when CD4+ T cells
MDSC-Like Cells
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were co-cultured with HD1B cells (Fig. 6B). These results indicate that HD1B cells exhibit a
similar immunosuppressive function as lal-/- MDSCs do.
mTOR signal inhibition reversed HD1B cell immunosuppressive function
mTOR protein expression was knocked down by mTOR siRNA in HD1B cells as confirmed by
Western blot analysis, which led to decreased mTOR and S6 phosphorylation (Fig. 7A). After
transfection with mTOR siRNAs, HD1B cells showed reduced immunosuppression on spleno-
cyte CD4+ T cell proliferation in the co-culture experiment (Fig. 7B), while control siRNAs
showed no reduced effect. Furthermore, lymphokine IL-4 and INFγ secretion was also
Fig 4. Mitochondrial membrane potential, ROS production, arginase, and IDOs in wild type (HD1A)
and lal-/- (HD1B) cells. (A) Live wild type (HD1A) and lal-/- (HD1B) cells were stained with JC1 to measure
the mitochondria membrane potential. JC1 fluorescent red staining represents a healthy membrane potential
state, while JC1 fluorescent green staining represents a damagedmembrane potential state. (B) The ROS
levels in wild type (HD1A) and lal-/- (HD1B) cells by flow cytometry analysis. Results are mean ± SD from
three independent experiments (n = 3), **, p< 0.001. (C) The arginase activity in HD1A and HD1B were
measured. The result is mean ± SD from three independent experiments (n = 3), **, p< 0.001. (D) The IDO1
and IDO2 expression levels were measured by Real-Time. The results are means ± SD from three
independent experiments (n = 3), **, p< 0.001.
doi:10.1371/journal.pone.0121001.g004
MDSC-Like Cells
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recovered when CD4+ T cells were co-cultured with HD1B cells that had been knocked down
by mTOR siRNA compared with those knocked down by control siRNA (Fig. 7C). Therefore,
mTOR over-activation is partially responsible for HD1B cell immunosuppressive function.
HD1B cells stimulate tumor cell proliferation
Recently, lal-/- MDSCs have been shown to directly stimulate cancer cell proliferation [11]. To
compare the tumor stimulatory effects between HD1A and HD1B cells, both cells were co-cul-
tured with CFSE-labeled B16 melanoma cells or LLC cells in vitro. After 3 days, more tumor
Fig 5. Over-activation of the mTOR signal pathway in wild type (HD1A) and lal-/- (HD1B) cells. (A)
Western blot analyses of the phosphorylation level of mTOR downstream effector pS6 in wild type (HD1A)
and lal-/- (HD1B) cells. Both cells were treated with solvent (S) or with mTOR inhibitor rapamycin (R) or
PP242 (P). (B) Flow cytometry analyses of the ROS levels of rapamycin or PP242 treated or untreated wild
type (HD1A) and lal-/- (HD1B) cells. Results are mean ± SD from three independent experiments (n = 3), p<
0.001. (C) Mitochondria membrane potential was analyzed in rapamycin or PP242 treated or untreated wild
type (HD1A) and lal-/- (HD1B) cells by JC1 staining. Treatment of mTOR inhibitors restored the mitochondria
membrane potential in lal-/- (HD1B) cells. (D) Antioxidant reagent NAC or Tempol treated or untreated wild
type (HD1A) and lal-/- (HD1B) cells were stained with JC1 to measure the mitochondria membrane potential.
Treatment of antioxidants restored the mitochondria membrane potential in lal-/- (HD1B) cells.
doi:10.1371/journal.pone.0121001.g005
MDSC-Like Cells
PLOS ONE | DOI:10.1371/journal.pone.0121001 March 25, 2015 12 / 20
cells were observed when co-cultured with HD1B cells compared with those co-cultured with
HD1A cells in flow cytometry analysis (Fig. 8A), suggesting that HD1B cells possess a stronger
stimulatory effect on both B16 melanoma cells and LLC cells. Knockdown of mTOR in HD1B
cells showed a decreased stimulatory effect on cancer cells (Fig. 8B). Surprisingly, knockdown
of mTOR in HD1A cells showed an increased stimulatory effect on cancer cells (Fig. 8B). Per-
haps the mTOR signaling plays differential roles in HD1A cells and HD1B cells. In an in vivo
model, when B16 melanoma cells were co-injected with HD1A or HD1B cells into syngeneic
C57BL/6 or allogeneic FVB/N wild type recipient mice, the tumor size and volume were much
larger in the group with HD1B cell co-injection than the group with HD1A cell co-injection in
both syngeneic and allogeneic background (Fig. 8C).
Discussion
MDSCs are heterogeneous immune cell populations involved in various pathogenic diseases.
Although it is doable, isolation of MDSCs from mice and humans is time consuming and
Fig 6. Immunosuppression on T cell proliferation and function by wild type (HD1A) and lal-/- (HD1B) cells. (A) CFSE labeled wild type CD4+ T cells
were stimulated with anti-CD3 and anti-CD28 antibodies, and co-cultured with wild type (HD1A) or lal-/- (HD1B) cells (1:30). CD3 and CD28 antibody
unstimulated CD4+ T cells served as a negative control. Results are mean ± SD from three independent experiments (n = 3), *, p< 0.05; **, p<0.01. (B)
Secretion of T cell releasing IL-2, IL-4 and INF-γ in the above co-culture experiment was measured to assess the CD4+ T cell function. Results are
mean ± SD from three independent experiments (n = 3), *, p< 0.05; **, p<0.01.
doi:10.1371/journal.pone.0121001.g006
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costly. Therefore, there is an urgency to establish an “MDSC-like” cell line for various biochem-
ical, immunological, physiological, pathological and pharmacological studies. Establishment of
such cell lines will greatly facilitate characterization of MDSCs biological functions. It will also
greatly benefit screening and discovery of new pharmacological drugs, as well as identifying
new immune therapeutic approaches to target MDSCs.
Fig 7. siRNA knockdown of mTOR inhibits immunosuppression on T cell proliferation and function of
lal-/- (HD1B) cells. (A) Western blot analyses showed the mTOR protein expression level, phosphorylated
mTOR, and phosphorylated S6 levels reduced in wild type (HD1A) and lal-/- (HD1B) cells by mTOR siRNA
knocking down. (B) T cell suppressive activity of HD1B was reduced upon mTOR knocking down by siRNA
transfection. Wild type (HD1A) or lal-/- (HD1B) cells were pretreated with control (C) siRNA or mTOR (mTOR)
siRNA. Treated cells were incubated with CFSE labeled wild type CD4+ T cells and stimulated with anti-CD3
and anti-CD28 antibodies. Results are mean ± SD from three independent experiments (n = 3), p< 0.05; (C)
Secretion of T cell releasing IL-4 in the above co-culture experiment was measured to assess the CD4+ T cell
function. Results are mean ± SD from three independent experiments (n = 3), p< 0.05.
doi:10.1371/journal.pone.0121001.g007
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Lipids have long been recognized not only as the nutrients for cell growth and structural
components, but also as the cell signaling molecules that have the capacity to trigger profound
physiological responses. Previously, we have done extensive studies to show that LAL is a criti-
cal enzyme that controls inflammation, especially MDSCs development and homeostasis.
Fig 8. Lal-/- cells (HD1B) stimulated cancer cells growth. (A) Wild type (HD1A) and lal-/- (HD1B) cells
were co-cultured with CFSE labeled LLC or B16 melanoma cells (5:1) for 3 days. The results are presented
as percentage of CFSE positive cells increased from none co-culture base line. The results are mean ± SD
from three independent experiments (n = 3), **, p< 0.01. (B) mTOR siRNA knockdown in lal-/- (HD1B) cells
inhibited the stimulatory activity of cancer cell growth (LLC and B16 melanoma cells). The same cell ratio was
used. The results are mean ± SD from three independent experiments (n = 3), **, p< 0.01; (C) B16
melanoma cells (2 X 105) that were mixed with the same amount of wild type (HD1A) or lal-/- (HD1B) cells
were left-side and right-side pair-injected subcutaneously into C57BL/6 or FVB/N mice. After 14 days, tumor
volumes were measured using the formula: (length X width2) /2. The results are mean ± SD from 11–12
independent experiments (n = 11–12), p values are listed in comparison of tumor sizes between co-injection
of wild type (HD1A) and lal-/- (HD1B) cells.
doi:10.1371/journal.pone.0121001.g008
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Deletion of this neutral lipid metabolic controlling enzyme induces massive MDSCs expansion
in lal-/- mice, which leads to immunosuppression and multiple pathogenic diseases including
cancer formation and metastasis [5–7,9,11–15,25]. These studies have firmly established the
functional roles of neutral lipid metabolism controlled by LAL in MDSCs development, ho-
meostasis and function. Based on these solid characterizations, lal-/- mouse model is an ideal
system to generate “MDSCs-like” cell lines. By crossbreeding wild type or lal-/- mice with
Immortomouse expressing a temperature-sensitive version of simian virus 40 large T antigen
[21], we have successfully established two myeloid-derived cell lines, HD1A (wild type myeloid
cell line) and HD1B (lal-/- myeloid cell line).
In lal-/- HD1B cells, more intensified lysosomal subcellular structures were observed by
both LysoTracker and LAMP1 staining studies compared with HD1A cells (Fig. 1B, C), impli-
cating that LAL deficiency increases lysosome genesis. In addition, the lysosomal structures in
HD1B cells were located around perinuclear areas, while lysosomal structures in HD1A were
spread out in the cytoplasm. This localization change implicates functional changes of lyso-
somes in HD1B cells. The lysosome functions far beyond the traditional cell component to de-
grade and recycle cellular waste. It is also involved in much broader functions such as
secretion, plasma membrane repair, cell signaling, autophagy and energy metabolism [26].
In addition to morphological changes, expression of several functional proteins critical for
fatty acid transportation across the plasma membrane or mitochondrial membrane, and meta-
bolic stress protein were investigated. CD36 is a scavenger receptor for modified LDL lipid par-
ticles and long-chain fatty acid uptake [27]. To compensate the inability of intracellular fatty
acid generation due to LAL deficiency, HD1B cells upregulated CD36 expression perhaps try-
ing to export more extracellular ones (Fig. 1D). On the other hand, due to the reduced intracel-
lular generation of fatty acids in HD1B cells, there is no change in expression of carnitine
O-palmitoyltransferase (CPT), the rate-limiting enzyme for long chain fatty acid entry into mi-
tochondria and fatty acid oxidation (FAO) (Fig. 1D). However, under the metabolic stress,
mTOR activated forkhead box protein O 3 (FOXO3) was upregulated in HD1B cells (Fig. 1D).
When high levels of ROS are generated, FOXOs translocate into the nucleus to activate both ly-
sosomal and proteasomal protein degradation. FOXO proteins activate the expression of genes
that encode superoxide dismutase and catalase enzymes (required for the detoxification of
ROS) [28,29]. It has also been shown that the transcription factor forkhead homeobox type
protein O1 (FoxO1) is induced by nutrient restriction in adipocytes and exerts transcriptional
control of lipid catabolism via the induction of LAL [30].
Co-regulators for histone acetyltransferases (HATs), including sirtuins (SIRTs) regulate the
levels of FOXO acetylation during oxidative stress. NAD+-dependent SIRTs coordinate a
switch from glucose to fatty acid oxidation during the acute inflammatory response [31]. At
least SIRT1 expression remains unchanged, suggesting that the switch from glucose to fatty
acid oxidation may not be needed in HD1B cells.
In the mitochondria, oxidative phosphorylation (OXPHOS) is the metabolic pathway to re-
form ATP by the oxidation of nutrients. There are several catabolic biochemical processes pro-
duce energy (in form of ATP), including glycolysis, the citric acid cycle, and β-oxidation of free
fatty acids. In fat catabolism, triglycerides are hydrolyzed to break into fatty acids and glycerol
by LAL. Fatty acids are further broken down through a process known as β-oxidation and re-
sults in acetyl-CoA, which can be used in the citric acid cycle in mitochondria. β-oxidation of
fatty acids with an odd number of methylene bridges produces propionyl CoA, which is con-
verted into succinyl-CoA and fed into the citric acid cycle. In the absence of the regular supply
of fatty acids during LAL deficiency, it seems that the energy consumption switches more to
the metabolic pathway on extracellular glucose consumption to fuel OXPHOS in HD1B cells.
This was first observed by gene microarray analysis, in which the glycolytic metabolic gene
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profile of bone marrow lal-/- MDSCs is increased [15]. Glycolysis breaks glucose (a six-carbon-
-molecule) down into pyruvate (a three-carbon molecule). Pyruvate moves into the mitochon-
dria to be converted into acetyl-CoA by decarboxylation and enters the citric acid cycle. As
demonstrated in Fig. 2, both glycolysis (measured by the pyruvate concentration) and TCA in
mitochondria (measured by the aconitase activity) were significantly elevated in HD1B cells.
This observation was further supported by increased expression of glucose transporters
(GLUT3, GLUT6, GLUT8, GLUT12, and CLUT13) in HD1B cells (Fig. 2). On the other hand,
there was no difference between expression levels of CPT1a, CPT1b and CPT1c that are re-
quired for transporting long-chain FA into the mitochondria in HD1A cells and HD1B cells
(Fig. 1D). There is a report showing that in IL-15 memory T cells, glucose is used to produce
FA for OXPHOS, which is dependent on LAL to funnel fatty acids into mitochondria for oxi-
dative phosphorylation [32]. This is unlikely in HD1B cells.
We previously reported that Affymetrix GeneChip microarray of lal-/- bone marrow Ly6G+
cells (almost all bone marrow Ly6G+ cells are CD11b+ in lal-/- mice) revealed over-activation
of the mTOR signaling pathway [15]. Pharmacological inhibition of mTOR blocked lal-/-
CD11b+Ly6G+ cell development and expansion [18]. It has been well documented that the
mTOR signaling controls mitochondrial functions, including maintaining proper membrane
potential and ROS production. ROS are generated as by-products of aerobic respiration and
various other catabolic and anabolic processes [33]. Mitochondria are the major producer of
ROS in cells at the electron transport chain. Electrons leak from the electron transport chain di-
rectly to oxygen, producing short-lived free radicals. A decline in mitochondrial function such
as damaged membrane potential leads to enhanced ROS production. Indeed, lal-/- Ly6G+ cells
showed damaged mitochondrial membrane potential and increased ROS production [15].
These abnormal mitochondrial functions can be reversed by mTOR pharmacological inhibi-
tors [18]. Similarly, the mTOR downstream gene S6 was hyper-phosphorylated in HD1B cells
compared with that in HD1A cells (Fig. 5A), indicating over-activation of mTOR signaling in
HD1B cells. Damaged mitochondrial membrane potential and increased ROS production were
observed as well in HD1B cells (Fig. 4A, B). Similar to those observed in isolated lal-/- MDSCs,
these abnormal mitochondrial activities can be blocked by treatment with mTOR pharmaco-
logical inhibitor rapamycin and PP242 (Fig. 5B and 5C), as well as by anti-ROS chemicals
(Fig. 5D). Interestingly, the mitochondrial structure in HD1B cells showed a more fission pat-
tern (dots), whereas HD1A showed a more fusion pattern (linear lines) morphologically by Mit
G staining (Fig. 3A). Importantly, pro-fusion protein Opa1 was down-regulated, while phos-
phorylation of pro-fission protein Drp1 was increased in HD1B cells compared with HD1A
cells (Fig. 3C). Mitochondria are double-membrane—bound subcellular dynamic organelles
that constantly fuse and divide. Mitochondrial fission and fusion processes are essential for mi-
tochondrial functions to meet the cellular activity of proliferation. Since the mitochondrial fis-
sion state indicates more cell proliferation, this is in agreement with a higher proliferative rate
of isolated lal-/- MDSCs [15] and HD1B cells (Fig. 3B). Compared with that in HD1A cells,
HD1B cells also increased the arginase activity, which is another important characteristic pa-
rameter for MDSCs [34], (Fig. 4C). Interestingly, IDO2 was highly overexpressed in HD1B
cells, whereas IDO1 did not (Fig. 4D). It has been reported that high-fat feeding induces IDO2
in the liver [35].
Functionally, the hallmark feature of MDSCs is to suppress T cell proliferation and function.
We have previously shown that lal-/- CD11b+Ly6G+ MDSCs exhibit strong immunosuppres-
sive function on T cell proliferation and lymphokine secretion. This is partially responsible for
the decreased T cell populations in lal-/- mice [12,14]. Therefore, it is essential to demonstrate
that HD1B cells possess immunosuppressive function before claiming it as an “MDSC-like”
cell line. When co-cultured with wild type CD4+ T cells in vitro and stimulated with anti-CD3
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and anti-CD28 antibodies, HD1B cells showed a strong suppressive activity on CD4+ T cell
proliferation (Fig. 6A), and TH1 INFγ, TH2 IL-4 secretion (Fig. 6B). After transfection with
mTOR siRNAs, HD1B cells showed a decreased immunosuppressive activity on CD4+ T cell
proliferation (Fig. 7B) and lymphokine secretion (Fig. 7C). This is also similar to what has been
observed in lal-/- CD11b+Ly6G+ MDSCs [18]. The second hallmark for lal-/- MDSCs is their
ability to directly stimulate cancer cell proliferation in vitro [11]. Interestingly and importantly,
HD1B cells also demonstrated stimulatory activity on cancer cells both in in vitro co-culture
experiment and in in vivo co-injection experiment, including LLC and B16 melanoma cancer
cell models (Fig. 8).
In summary, several parallel studies showed resemblances between lal-/- MDSCs and the
newly established MDSC-like HD1B cell line, including but not limited to: 1) Both lal-/-
MDSCs and HD1B cells showed increased glycolytic metabolic activity; 2) Both lal-/- MDSCs
and HD1B cells showed over-activation of mTOR signaling; 3) Both lal-/- MDSCs and HD1B
cells showed the increased mitochondrial membrane potential damage and altered expression
of metabolic molecules involved in mitochondrial functions; 3) Both lal-/- MDSCs and HD1B
cells showed increased ROS production; 4) Both lal-/- MDSCs and HD1B cells showed immu-
nosuppressive function on T cell proliferation and lymphokine secretion; 5) All above patho-
genic cellular activities were corrected by either mTOR pharmacological inhibitors, or by
siRNA knockdown in lal-/- MDSCs and HD1B cells; 6) Both lal-/- MDSCs and HD1B cells
showed stimulation on cancer cell proliferation and growth. Taken all together, this newly es-
tablished HD1B cell line shows similar characteristics of MDSCs from lal-/- mice, and support
a concept that LAL supports FAO in myeloid cells and that lysosomal lipolysis contributes to
normal function of myeloid cells.
In our characterization, one discrepancy between lal-/- MDSCs and HD1B cells is that
HD1B cells are negative for CD11b and Ly6G, two hallmarks for MDSCs. Expression of cell
surface markers (e.g. CD11b and Ly6G) depends on extracellular stimuli (e.g. cytokines, che-
mokines) in the surround environment in vivo. Since HD1A and HD1B are cell lines cultured
in vitro, which are separated from the in vivo environment, CD11b and Ly6G negative expres-
sion may result from absence of stimulatory molecules for these two markers in the culture me-
dium. This interesting observation indicates that CD11b and Ly6G may not be responsible for
MDSCs malfunction. Therefore, to define an MDSC cell line, one has to rely on its functions,
not a few cell surface markers. Nevertheless, both HD1A and HD1B cell lines will be useful in
the future to explore the LAL functions in numerous cellular processes and functions of mye-
loid cells, especially MDSCs. The myeloid cell lines will also be useful for pharmacological iden-
tification of drugs to suppress MDSCs expansion and function in multiple inflammation-
induced diseases which involve MDSCs.
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